Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Diabetes Complications ; 22(5): 339-47, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18413164

RESUMO

AIMS: This study was conducted to evaluate the suitability of a new minipig model for investigating aspects of diabetes such as delayed gastric emptying and glucose metabolism abnormalities, and to test the effects of mitemcinal (GM-611), an orally active erythromycin-derived motilin receptor agonist, on gastric emptying and postprandial glucose in normal and diabetic minipigs. METHODS AND RESULTS: Intravenous injection of 300 mg/kg streptozotocin (STZ) to 5-week-old minipigs induced moderate hyperglycemia (about 200 mg/dl) for >80 weeks without insulin treatment. Decreased insulin production (P<.05), increased area under the glucose curve (P<.05), and slower glucose disappearance (P<.05) were demonstrated, and there was no severe inhibition of body weight gain, liver failure, or renal failure. Gastric emptying was significantly delayed in diabetic minipigs (P<.05) at 80 weeks, but not at 40 weeks, post-STZ. Oral administration of mitemcinal (5 mg/kg) at 80 weeks accelerated gastric emptying and induced a similar postprandial glucose profile in normal and diabetic minipigs with delayed gastric emptying. CONCLUSIONS: The new diabetic minipig model showed suitability for investigating diabetes, gastric emptying, and plasma glucose excursions. Since delayed gastric emptying and irregular plasma glucose excursions are characteristic of diabetic gastroparesis, the accelerating and regulating effects of mitemcinal on this model add to the existing evidence that mitemcinal is likely to be useful for treating diabetic gastroparesis.


Assuntos
Glicemia/efeitos dos fármacos , Diabetes Mellitus Experimental/complicações , Eritromicina/análogos & derivados , Esvaziamento Gástrico/efeitos dos fármacos , Gastroparesia/tratamento farmacológico , Período Pós-Prandial/efeitos dos fármacos , Administração Oral , Animais , Diabetes Mellitus Experimental/induzido quimicamente , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/fisiopatologia , Avaliação Pré-Clínica de Medicamentos , Eritromicina/administração & dosagem , Eritromicina/farmacologia , Eritromicina/uso terapêutico , Esvaziamento Gástrico/fisiologia , Fármacos Gastrointestinais/administração & dosagem , Fármacos Gastrointestinais/farmacologia , Fármacos Gastrointestinais/uso terapêutico , Gastroparesia/induzido quimicamente , Gastroparesia/fisiopatologia , Ilhotas Pancreáticas/efeitos dos fármacos , Ilhotas Pancreáticas/fisiopatologia , Rim/efeitos dos fármacos , Rim/fisiopatologia , Fígado/efeitos dos fármacos , Fígado/fisiopatologia , Masculino , Período Pós-Prandial/fisiologia , Estreptozocina , Suínos , Porco Miniatura
2.
J Bacteriol ; 188(17): 6143-52, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16923881

RESUMO

Rhodopseudomonas palustris is a purple, facultatively phototrophic bacterium that uses hydrogen gas as an electron donor for carbon dioxide fixation during photoautotrophic growth or for ammonia synthesis during nitrogen fixation. It also uses hydrogen as an electron supplement to enable the complete assimilation of oxidized carbon compounds, such as malate, into cell material during photoheterotrophic growth. The R. palustris genome predicts a membrane-bound nickel-iron uptake hydrogenase and several regulatory proteins to control hydrogenase synthesis. There is also a novel sensor kinase gene (RPA0981) directly adjacent to the hydrogenase gene cluster. Here we show that the R. palustris regulatory sensor hydrogenase HupUV acts in conjunction with the sensor kinase-response regulator protein pair HoxJ-HoxA to activate hydrogenase expression in response to hydrogen gas. Transcriptome analysis indicated that the HupUV-HoxJA regulatory system also controls the expression of genes encoding a predicted dicarboxylic acid transport system, a putative formate transporter, and a glutamine synthetase. RPA0981 had a small effect in repressing hydrogenase synthesis. We also determined that the two-component system RegS-RegR repressed expression of the uptake hydrogenase, probably in response to changes in intracellular redox status. Transcriptome analysis indicated that about 30 genes were differentially expressed in R. palustris cells that utilized hydrogen when growing photoheterotrophically on malate under nitrogen-fixing conditions compared to a mutant strain that lacked uptake hydrogenase. From this it appears that the recycling of reductant in the form of hydrogen does not have extensive nonspecific effects on gene expression in R. palustris.


Assuntos
Regulação Bacteriana da Expressão Gênica , Hidrogênio/metabolismo , Hidrogenase/metabolismo , Rodopseudomonas/genética , Rodopseudomonas/metabolismo , Proteínas de Bactérias/metabolismo , Meios de Cultura , Proteínas de Homeodomínio/metabolismo , Hidrogenase/genética , Malatos , Dados de Sequência Molecular , Família Multigênica , Fixação de Nitrogênio , Proteínas Quinases/metabolismo , Proteínas Repressoras/metabolismo , Rodopseudomonas/crescimento & desenvolvimento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA